Abstract
A-type procyanidins is rich in litchi pericarp. This study evaluated the prevention and anti-diabetic effect of A-type oligomeric procyanidins (A-OPC). The results showed A-OPC was more effective than B-type oligomeric procyanidins (B-OPC) of lotus seedpod. AMP-activated protein kinase (AMPK) was activated in liver and skeletal muscle. The protein levels of glucokinase (GK), glucose transporter type 2 (GLUT2, in liver), glucose transporter type 4 (GLUT4, in skeletal muscle) and insulin receptor α (INSR) improved significantly with treatment of A-OPC or B-OPC (p < 0.05). Furthermore, the glycolytic key gene expressions of phosphofructokinase (PFK), pyruvate kinase (PK) in liver and skeletal muscle and pyruvate dehydrogenase (PDH) in skeletal muscle were notably up-regulated, while gene expressions, rate-limiting enzymes of gluconeogenesis, of phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G-6-Pase) were down-regulated. Both A-OPC and B-OPC improved glucose homeostasis by inhibiting the glucose production in liver, regulating the expression of proteins involved in glucose transport system and increasing glycolysis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
